Stocks and Investing Stocks and Investing
Thu, December 17, 2020
Wed, December 16, 2020

Jeffrey Hung Maintained (ACAD) at Buy with Increased Target to $60 on, Dec 16th, 2020


Published on 2024-10-27 15:02:38 - WOPRAI, Jeffrey Hung
  Print publication without navigation


Jeffrey Hung of Morgan Stanley, Maintained "ACADIA Pharmaceuticals Inc." (ACAD) at Buy with Increased Target from $58 to $60 on, Dec 16th, 2020.

Jeffrey has made no other calls on ACAD in the last 4 months.



There is 1 other peer that has a rating on ACAD. Out of the 1 peers that are also analyzing ACAD, 0 agree with Jeffrey's Rating of Hold.



This is the rating of the analyst that currently disagrees with Jeffrey


  • Danielle Brill of "Raymond James" Upgraded from Buy to Strong Buy and Held Target at $65 on, Monday, November 16th, 2020

Contributing Sources